My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 140

    1.

    Influence of metabolic control on splanchnic glucose uptake, insulin sensitivity, and the time required for glucose absorption in patients with type 1 diabetes.

    Georg P, Kautzky-Willer A, Mahdjoobian K, Hofer A, Prager R, Pacini G, Ludvik BH.

    Diabetes Care. 2002 Nov;25(11):2042-7.PMID: 12401754 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.

    Bajaj M, Suraamornkul S, Pratipanawatr T, Hardies LJ, Pratipanawatr W, Glass L, Cersosimo E, Miyazaki Y, DeFronzo RA.

    Diabetes. 2003 Jun;52(6):1364-70.PMID: 12765945 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus.

    Ludvik B, Nolan JJ, Roberts A, Baloga J, Joyce M, Bell JM, Olefsky JM.

    J Clin Invest. 1997 Nov 1;100(9):2354-61.PMID: 9410915 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes.

    Bajaj M, Pratipanawatr T, Berria R, Pratipanawatr W, Kashyap S, Cusi K, Mandarino L, DeFronzo RA.

    Diabetes. 2002 Oct;51(10):3043-8.PMID: 12351445 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A noninvasive method to measure splanchnic glucose uptake after oral glucose administration.

    Ludvik B, Nolan JJ, Roberts A, Baloga J, Joyce M, Bell JM, Olefsky JM.

    J Clin Invest. 1995 May;95(5):2232-8.PMID: 7738188 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Glycemic control determines hepatic and peripheral glucose effectiveness in type 2 diabetic subjects.

    Hawkins M, Gabriely I, Wozniak R, Reddy K, Rossetti L, Shamoon H.

    Diabetes. 2002 Jul;51(7):2179-89.PMID: 12086948 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?

    Burén J, Lindmark S, Renström F, Eriksson JW.

    Metabolism. 2003 Feb;52(2):239-45.PMID: 12601640 [PubMed - indexed for MEDLINE]Related articles

    8.

    Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control.

    Zhang L, Krzentowski G, Albert A, Lefebvre PJ.

    Diabetes Care. 2001 Jul;24(7):1275-9.PMID: 11423515 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

    Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

    Clin Ther. 2005 Sep;27(9):1383-91.PMID: 16291411 [PubMed - indexed for MEDLINE]Related articles

    10.

    Leisure time physical activity is associated with poor glycemic control in type 1 diabetic women: the FinnDiane study.

    Wadén J, Tikkanen H, Forsblom C, Fagerudd J, Pettersson-Fernholm K, Lakka T, Riska M, Groop PH; FinnDiane Study Group.

    Diabetes Care. 2005 Apr;28(4):777-82.PMID: 15793172 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients.

    Makris K, Spanou L, Rambaouni-Antoneli A, Koniari K, Drakopoulos I, Rizos D, Haliassos A.

    Diabet Med. 2008 Feb;25(2):174-8.PMID: 18290858 [PubMed - indexed for MEDLINE]Related articles

    12.

    Demonstration of glycated insulin in human diabetic plasma and decreased biological activity assessed by euglycemic-hyperinsulinemic clamp technique in humans.

    Hunter SJ, Boyd AC, O'Harte FP, McKillop AM, Wiggam MI, Mooney MH, McCluskey JT, Lindsay JR, Ennis CN, Gamble R, Sheridan B, Barnett CR, McNulty H, Bell PM, Flatt PR.

    Diabetes. 2003 Feb;52(2):492-8.PMID: 12540626 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Insulin resistance is localized to skeletal but not heart muscle in type 1 diabetes.

    Nuutila P, Knuuti J, Ruotsalainen U, Koivisto VA, Eronen E, Teräs M, Bergman J, Haaparanta M, Voipio-Pulkki LM, Viikari J, et al.

    Am J Physiol. 1993 May;264(5 Pt 1):E756-62.PMID: 8498497 [PubMed - indexed for MEDLINE]Related articles

    14.

    Youth type 2 diabetes: insulin resistance, beta-cell failure, or both?

    Gungor N, Bacha F, Saad R, Janosky J, Arslanian S.

    Diabetes Care. 2005 Mar;28(3):638-44.PMID: 15735201 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.

    Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A.

    Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.PMID: 17919531 [PubMed - indexed for MEDLINE]Related articles

    16.

    Insulin action and skeletal muscle blood flow in patients with Type 1 diabetes and microalbuminuria.

    Wiggam MI, Hunter SJ, Ennis CN, Sheridan B, Atkinson AB, Bell PM.

    Diabetes Res Clin Pract. 2001 Aug;53(2):73-83.PMID: 11403855 [PubMed - indexed for MEDLINE]Related articles

    17.

    Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans.

    Bajaj M, Berria R, Pratipanawatr T, Kashyap S, Pratipanawatr W, Belfort R, Cusi K, Mandarino L, DeFronzo RA.

    Am J Physiol Endocrinol Metab. 2002 Aug;283(2):E346-52.PMID: 12110541 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy.

    Ozmen B, Boyvada S.

    J Diabetes Complications. 2003 May-Jun;17(3):128-34.PMID: 12738396 [PubMed - indexed for MEDLINE]Related articles

    19.

    Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control.

    Iozzo P, Hallsten K, Oikonen V, Virtanen KA, Kemppainen J, Solin O, Ferrannini E, Knuuti J, Nuutila P.

    J Clin Endocrinol Metab. 2003 May;88(5):2055-60.PMID: 12727954 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.

    Herz M, Johns D, Reviriego J, Grossman LD, Godin C, Duran S, Hawkins F, Lochnan H, Escobar-Jiménez F, Hardin PA, Konkoy CS, Tan MH.

    Clin Ther. 2003 Apr;25(4):1074-95.PMID: 12809958 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity